NPNP-001 injection for knee osteoarthritis pain
Part of Bones, joints & muscles clinical trials.
This study tests a new medicine called NPNP-001 for people with knee osteoarthritis who have not gotten enough relief from other treatments. The medicine is given as an injection into the knee to see if it can reduce pain and improve function.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 40 years or older.
- You have knee pain when standing or walking that measures at least 40 out of 100 on a pain scale.
- You have tried other treatments (like pain meds or physical therapy) for at least 3 months, and they didn't help enough.
- You do not have rheumatoid arthritis, gout, or other types of arthritis besides osteoarthritis (wear-and-tear arthritis).
- You are not allergic to salmon, shrimp, or crab.
- You have not had a knee replacement or certain knee surgeries in the past 6 months.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new injectable filler called ALLOHEAL, injected directly into the knee joint to reduce pain and improve function in people with knee osteoarthritis. The filler is designed to cushion the knee joint and may help reduce pain and stiffness.
This trial tests a gel-like injection (Conjuran) given twice to help with knee osteoarthritis pain. It is for people with mild to moderate knee arthritis who have pain when standing or walking.
This study tests a new stem cell treatment injected into the knee to see if it can reduce pain and improve function in people with knee osteoarthritis. It may be an option for those who have had persistent knee pain for more than six months.
This trial tests an injectable medication called RAB001 for people with knee osteoarthritis that hasn't improved with other treatments. The goal is to see if it's safe and helps reduce pain.
This trial tests an injection called PTP-001 (MOTYS) for people with mild to moderate knee osteoarthritis. It aims to see if the injection can reduce knee pain and improve function.
This study tests an experimental injection called GNSC-001 given directly into the knee to see if it can reduce pain and improve knee function in people with knee osteoarthritis. If you join, you'll have one injection and then be followed for a year, and you'll need to stop your usual knee pain medicines during the study.
Hear when a new Knee Osteoarthritis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.